Product Information

OLMESARTAN MEDOXOMIL 5 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0644 per EA under NDC 31722085290. Its NADAC has been published 61 times since Sep 24, 2025.

FDA first approved this application on Oct 31, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN MEDOXOMIL 5 MG TAB

OLMESARTAN MEDOXOMIL
$0.0644per EA

Strength

5 mg/1

NDC

31722085290

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

Generic (ANDA)

FDA Application

ANDA205499

FDA Approved

10/31/2024

TE Code

AB

On Market Since

5/23/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has been published 61 times since Sep 24, 2025, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0644 per EA
All-time high$0.0644 (Nov 18, 2026)
All-time low$0.0551 (Aug 19, 2026)
52-week high$0.0644
52-week low$0.0551
Median price$0.0577
Average price$0.0579
Largest weekly change+6.3% (Oct 21, 2026)
Weeks tracked61
Tracking sinceSep 24, 2025

Price History

1W

+5.3%

1M

+12.0%

3M

+16.8%

6M

+11.6%

1Y

+8.5%

3Y

N/A

5Y

N/A

All

+9.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLMESARTAN MEDOXOMIL 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 5 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.0644 per EA (NDC 31722085290), effective Nov 18, 2026.

How has the price of OLMESARTAN MEDOXOMIL 5 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has risen 9.9%. It has been tracked across 61 weekly CMS publications since Sep 24, 2025.

What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 5 MG TAB?

Since Sep 24, 2025, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has ranged from a low of $0.0551 (Aug 19, 2026) to a high of $0.0644 (Nov 18, 2026), with a median of $0.0577 per EA.

Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 5 MG TAB?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 5 MG TAB, is $0.0622 per EA — about 3% below OLMESARTAN MEDOXOMIL 5 MG TAB.

Who manufactures OLMESARTAN MEDOXOMIL 5 MG TAB?

OLMESARTAN MEDOXOMIL 5 MG TAB (NDC 31722085290) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.